Legislative & Policy

NMBio provides its membership with timely and relevant information about the condition of legal and policy issues of concern to the bioscience community. The national lead is Bio, the world's largest biotechnology advocacy and support organization. Below are recent documents and policy positions with regard to contemporary topics facing the biotechnology community.

Patent Reform Topics

BIO Statement on Patent Reform - Written Testimony of The Biotechnology Industry Organization (BIO) Before the United States Senate, Committee on the Judiciary, March 10, 2009

Patent Reform Act Letter - Bio position on the proposed Patent Reform legislation

Bio News - Bio Opposes the Patent Reform Act of 2007

NMBio Opposition Letter - NMBio letter to Senator Domenici

Testimony - BIO Testifies on Patent Reform Act

Senate Letter - Opposing Patent Reform Act of 2007 w/signatures


SBIR Topics

SBIR Program Due for Reauthorization

 

Tax Code Topics

Bio News - Bio Supports Bill to Modernize Tax Code

 

Topic, Other

Bio News - EPA Report Recognizes Contributions Industrial Biotechnology Makes to Pollution Prevention

Upcoming Events

  • Oct. 12, 2010 11:30 am, BioMedical Tuesday in Los Alamos, Quasi-Monte Carlo integration within a fixed reference frame provides an efficient method of transforming the volume of a specific molecular conformation into a binary encoding of the shape of that conformation. We explore the use of this method in terms of volume estimation, shape alignment, shape fingerprint generation, and shape/pharmacophore feature analysis, all in the general context of drug discovery.